Cooper Financial Group Vertex Pharmaceuticals Inc Transaction History
Cooper Financial Group
- $808 Million
- Q4 2024
A detailed history of Cooper Financial Group transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cooper Financial Group holds 4,682 shares of VRTX stock, worth $2.15 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
4,682
Previous 4,031
16.15%
Holding current value
$2.15 Million
Previous $1.87 Million
0.59%
% of portfolio
0.23%
Previous 0.25%
Shares
13 transactions
Others Institutions Holding VRTX
# of Institutions
1,751Shares Held
227MCall Options Held
1.64MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.7 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.78 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.5 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.79 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...